The Max Foundation Welcomes New Member to Executive Team

The Max Foundation Welcomes New Member to Executive Team

The Max Foundation is thrilled to announce the hiring of Patricia Pearce as Chief Financial Officer (CFO) and Vice President (VP) of Administration. She joins the team at our Seattle headquarters beginning on Monday, July 30th.

Patricia brings a wealth of knowledge and experience to our organization, having been a senior member of staff at PATH during their exponential growth. Her addition to the team will help to ensure The Max Foundation’s continued success during our own period of rapid expansion, and serve as a crucial component in fulfilling the final piece of our 2015 strategic plan – improving our systems and processes.

Beyond her immediate contributions as CFO, Patti will also provide invaluable leadership as VP of Administration, building out our Accounting, Facilities, Human Resources, and Information Technology departments.

“I have total confidence in Patti,” said Pat Garcia-Gonzalez, CEO. “She is the perfect fit for this new leadership role within The Max Foundation. Her extensive experience in the INGO sector will greatly benefit our organization in both the short- and long-term, and provide us with another leader who can guide us to our vision of the future.”

See All News

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

Related Articles

  • CMLPath to Care

    CMLPath to Care

    In 2017 The Max Foundation, through its subsidiary MaxAid, and Novartis have renewed their commitment to patients by launching CMLPath to Care™ a new collaboration aimed at providing humanitarian access to treatment for CML and other rare cancers for those patients for whom no other form of local treatment access exists today. CMLPath to Care consists of humanitarian product donations and funding support from Novartis to Max, and an innovative new distribution model developed and implemented by Max and its international distributor, under the Max Access Solution umbrella.

  • Spot On CML: Improving CML Diagnostics One Patient at a Time

    Spot On CML: Improving CML Diagnostics One Patient at a Time

    February 21, 2018 · The Max Foundation and Dr. Jerry Radich of the Fred Hutchinson Cancer Research Center are partnering to help tackle the problem of access to accurate tests for chronic myeloid leukemia (CML) diagnostics in low- and middle-income countries through Spot On CML. Spot On CML is a low-cost, paper-based diagnostic testing method for CML, developed by Dr. Radich’s lab at Fred Hutch. Through a Spot On CML test, a physician spots a patient’s blood onto a paper test card and sends it to Dr. Radich’s lab for processing, where they perform accurate diagnostic testing on the samples even after weeks of transport. Once patients are diagnosed, The Max Foundation connects them with available treatments free of charge.

  • The Max Foundation’s access program exceeds 10 million daily doses of cancer treatment distributed to patients worldwide

    The Max Foundation’s access program exceeds 10 million daily doses of cancer treatment distributed to patients worldwide

    Since the launch of Max Access Solutions in 2017, The Max Foundation has delivered over 10 million daily doses of cancer treatment to patients in more than 70 low- and middle-income countries.